148 related articles for article (PubMed ID: 27522752)
1. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Invited Lecture: 1. Diabetes and its complication, focusing on diabetic nephropathy].
Haneda M
Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2040-50. PubMed ID: 27522752
[No Abstract] [Full Text] [Related]
2. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 15. Treatment of diabetic nephropathy].
Utsunomiya K
Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2453-9. PubMed ID: 24228441
[No Abstract] [Full Text] [Related]
3. [109th Scientific Meeting of the Japanese Society of Internal Medicine: invited lecture: 4. Development of new therapeutics based on the progression mechanisms of diabetic nephropathy].
Makino H
Nihon Naika Gakkai Zasshi; 2012 Sep; 101(9):2488-96. PubMed ID: 23205423
[No Abstract] [Full Text] [Related]
4. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
[TBL] [Abstract][Full Text] [Related]
5. [108th Scientific Meeting of the Japanese Society of Internal Medicine: educational lecture: 2. Therapeutic strategy for diabetic nephropathy].
Koya D
Nihon Naika Gakkai Zasshi; 2011 Sep; 100(9):2592-8. PubMed ID: 22117358
[No Abstract] [Full Text] [Related]
6. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 3. Clinical epidemiology of CKD].
Iseki K
Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2242-6. PubMed ID: 27522785
[No Abstract] [Full Text] [Related]
7. Diabetes and chronic kidney disease.
Kowalski A; Krikorian A; Lerma EV
Dis Mon; 2015 Sep; 61(9):378-86. PubMed ID: 26318277
[No Abstract] [Full Text] [Related]
8. [Pathophysiology of diabetic nephropathy: a literature review].
Meza Letelier CE; San MartÃn Ojeda CA; Ruiz Provoste JJ; Frugone Zaror CJ
Medwave; 2017 Jan; 17(1):e6839. PubMed ID: 28112712
[TBL] [Abstract][Full Text] [Related]
9. Diabetic Nephropathy: A Comparison of the Clinical and Pathological Features between the CKD Risk Classification and the Classification of Diabetic Nephropathy 2014 in Japan.
Furuichi K; Shimizu M; Hara A; Toyama T; Wada T
Intern Med; 2018 Dec; 57(23):3345-3350. PubMed ID: 30101924
[TBL] [Abstract][Full Text] [Related]
10. [113th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Recent Progresses in Diabetic Nephropathy].
Wada T
Nihon Naika Gakkai Zasshi; 2016 Sep; 105(9):1870-6. PubMed ID: 30170352
[No Abstract] [Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.
Penno G; Garofolo M; Del Prato S
Nutr Metab Cardiovasc Dis; 2016 May; 26(5):361-73. PubMed ID: 27105869
[TBL] [Abstract][Full Text] [Related]
12. [Novel diagnostic and therapeutic procedures in diabetic nephropathy].
Pont'uch P
Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S57-62. PubMed ID: 27124974
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between the Classification of Diabetic Nephropathy 2014 and the classification of CKD stages].
Shimizu M; Wada T
Nihon Rinsho; 2016 Apr; 74 Suppl 2():164-9. PubMed ID: 27266081
[No Abstract] [Full Text] [Related]
14. Early diabetic nephropathy: assessment and potential therapeutic interventions.
Rosenstock J; Raskin P
Diabetes Care; 1986; 9(5):529-45. PubMed ID: 3533477
[TBL] [Abstract][Full Text] [Related]
15. [113th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Invited Lecture: Chronic Kidney Disease Initiatives in Japan and Future Perspective].
Matsuo S
Nihon Naika Gakkai Zasshi; 2016 Sep; 105(9):1600-10. PubMed ID: 30169920
[No Abstract] [Full Text] [Related]
16. Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.
Takashima H; Yoshida Y; Nagura C; Furukawa T; Tei R; Maruyama T; Maruyama N; Abe M
Diab Vasc Dis Res; 2018 Sep; 15(5):469-472. PubMed ID: 29923427
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and management of diabetic nephropathy].
Kitada M; Koya D
Nihon Rinsho; 2015 Dec; 73(12):2037-43. PubMed ID: 26666150
[TBL] [Abstract][Full Text] [Related]
18. Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.
Krolewski AS
Diabetes Care; 2015 Jun; 38(6):954-62. PubMed ID: 25998286
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease in diabetes.
; McFarlane P; Gilbert RE; MacCallum L; Senior P
Can J Diabetes; 2013 Apr; 37 Suppl 1():S129-36. PubMed ID: 24070935
[No Abstract] [Full Text] [Related]
20. The development, enhancement, and reversal of the secondary complications of diabetes mellitus.
Steffes MW; Brown DM; Mauer SM
Hum Pathol; 1979 May; 10(3):293-9. PubMed ID: 112028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
